Summary:
A Russian company has developed an innovative software - a predictive analytics and risk management platform in healthcare based on machine learning. The platform is designed for automatic analysis of depersonalized medical data in order to predict the risks of developing diseases. The system is intended for doctors, healthcare organizations and insurance companies. The company is looking for reliable partners to conclude a license agreement.
Description:
The Russian company develops various innovative products. The company offers a developed innovative platform for predictive analytics and risk management in healthcare based on artificial intelligence. This platform is designed for automatic analysis of depersonalized medical data in order to predict the possible development of diseases and their complications at the personal and population level. The platform is the first Russian artificial intelligence system for healthcare, which has successfully passed independent technical and clinical trials and is registered by Roszdravnadzor as a software medical product.
The developed system is able to analyze a variety of data on the patient's health status using intelligent big data processing methods, such as machine learning, NLP technologies, predictive modeling, etc. The platform identifies risk factors for diseases and predicts the likelihood of complications or even death of the patient. Forms individual recommendations for the prevention of the disease. The system can detect 40 diseases as suspected in the patient and 14 diseases as a risk (negative development). The platform includes several key services (products):
- Extract clinically relevant information from unstructured electronic medical records
- Formation of a single digital passport of the patient
- Identification of suspicions of missed diseases by the doctor
- Identification of risk factors for the development of chronic non-communicable diseases
- Prediction of possible negative events in the patient's health, including
the deterioration of existing diseases, hospitalization or death.
The platform is intended for use by healthcare organizations, doctors to identify and epidemiologically monitor high-risk patients and reduce medical errors. The development can be used by pharmaceutical companies to improve the efficiency of work and research. in addition, this platform can help insurance companies reduce the cost of patient care and insurance claims.
The Russian company is interested in finding foreign partners from the field of health care, insurance companies, developers of online services to conclude a mutually beneficial license agreement. As a result of this agreement, the Russian company will provide the partner with the right to use this system. The partner does not have to make their own changes and engage in developments that contradict the Russian company. More precise terms of this agreement will be discussed in detail with the potential partner.
Type (e.g. company, R&D institution…), field of industry and Role of Partner Sought:
Type: SMEs, large medical organizations, clinics, hospital networks, diagnostic and research centers, insurance companies, developers.
Role: a potential partner will acquire a license to use the innovative platform for their own purposes.
Stage of Development:
Already on the market
IPR Status:
Secret Know-how
External code:
BORU20210518001